Novartis’ randomized, double-blind, placebo-controlled CAN-COVID trial failed to meet endpoints
On Nov. 5, 2020, Novartis announced data from an interim analysis for the randomized, double-blind, placebo-controlled CAN-COVID trial…
-
-
Neoleukin Therapeutics announced publication of de novo protein decoys that block COVID-19 infection
On Nov. 5, 2020, Neoleukin Therapeutics announced the publication in Science of research describing novel molecules designed to…
-
Relief Therapeutics and NeuroRx announced continuation of RLF-100ﾙ trial for treatment of COVID-19 respiratory failure
On Nov. 5, 2020, RELIEF THERAPEUTICS and NeuroRx announced that the independent Data Monitoring Committee (DMC) voted unanimously…
-
Novavax and Commonwealth of Australia announced agreement for acquisition of Novavax COVID-19 vaccine
On Nov. 4, 2020, Novavax announced the signing of a non-binding Heads of Terms document with the Australian…
-
Mateon’s C001- A Global phase 2 study for OT-101 against COVID-19 received cleareence for patient enrollment
On Nov. 4, 2020, Mateon Therapeutics announced the receipt of approval from Instituto Nacional de Salud (INS), the…
-
McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics of breast and ovarian cancer
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
-
Rapid COVID-19 test, Oxsed RaViD Direct, used at Heathrow and trials at Hong Kong International Airport
On Nov. 4, 2020, the University of Oxford announced that its rapid COVID-19 test was being used at…
-
Research confirmed obesity is a cause of kidney disease
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
-
Stanford developed CRISPR ‘lab on a chip’ for detecting COVID-19
On Nov. 4, 2020, using the cutting-edge genetic editing technique known as CRISP ‘lab on a chip’ technology,…
-
Biotechnology | COVID-19 | Medicine | NIH | Therapeutics | Vaccine
Medigen Vaccines and NIHE partnered to develop COVID-19 vaccine in Vietnam
On Nov. 3, 2020, Medigen Vaccine Biologics (MVC) and the National Institute of Hygiene and Epidemiology (NIHE), a…
-
NIAID scientists and colleagues revealed new tethering mechanism in a gram-negative cell envelope
On Nov. 3, 2020, NIAID researchers and colleagues announced they had discovered a mechanism that some bacteria, such…
-
Neighborhood conditions associated with children’s cognitive function
On Nov. 3, 2020, a study published in JAMA Network Open showed that children from poorer neighborhoods performed…
-
OraSure’s DNA Genotek subsidiary received FDA EUA for its ORAcollect-RNA saliva collection device for SARS CoV-2
On Nov. 3, 2020, OraSure Technologies announced its DNA Genotek subsidiary has received Emergency Use Authorization from the…
-
ACON Laboratories announced the launch of its Flowflexﾙ Antigen COVID-19 test
On Nov. 2, 2020, ACON Laboratories announced the launch of its Flowflexﾙ SARS-COV-2 Antigen Rapid Test. The Flowflex…
-
Innovation Pharmaceuticals received pre-IND response from FDA on COVID-19 trial
On Nov. 2, 2020, Innovation Pharma announced receipt of written feedback from the FDA that is in general…
-
Novavax announced facility expansion to support global vaccine development
On Nov. 2, 2020, Novavax announced the expansion of its Maryland campus to accommodate the company’s rapid growth…
-
COVID-19 pandemic sparked 3D printing engineering innovation
On Nov. 2, 2020, Pacific Northwest National Laboratory (PNNL) announced that in the Spring of 2020, as news…
-
Immunic announced 200 patients enrolled in phase 2 CALVID-1 trial of IMU-838 for treatment of COVID-19
On Nov. 2, 2020, Immunic announced that the company had enrolled and randomized 200 patients, pre-specified in the…
-
Walgreens Boots Alliance and McKesson completed formation of German wholesale joint venture
On Nov. 2, 2020, Walgreens Boots Alliance (WBA) and McKesson announced the completion of their previously announced agreement…
-
Brilacidin exhibited potent in vitro antiviral activity against SARS-CoV-2
On Nov. 1, 2020, scientists announced that increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs),…
-
Patriot Express Travel at BWI, SEATAC required on-site, rapid COVID-19 testing
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
-
389,000 BinaxNOW COVID-19 tests distributed to historically black colleges and universities
On Oct. 31, 2020, the U.S. Department of Health and Human Services (HHS) announced that 389,040 state-of-the-art Abbott…
-
InBios awarded $12.7M to boost production of two COVID-19 diagnostics
On Oct. 31, 2020, the U.S. Department of Health and Human Services and the U.S. Department of Defense…
-
Kaiser Permanente Research Institute enrolled volunteers in a phase 3 clinical trial to evaluate COVID-19 vaccine
On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase…
-
Innovation Pharma and George Mason University released lab testing results for Brilacidinﾒs COVID-19 treatment
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
-
Trials of University of Oxford’s Coronavirus vaccine began in Kenya
On Oct. 30, 2020, the University of Oxford announced that Kenya had joined the global efforts in search…
-
The CDC issued framework for resuming safe and responsible cruise ship passenger operations
On Oct. 30, 2020, the Centers for Disease Control and Prevention (CDC) issued a Framework for Conditional Sailing…
-
HHS and DOD announced $12.7 million contract with InBios to boost US production of rapid COVID-19 tests
On Oct. 30, 2020, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of…
-
Icosavax launched COVID-19 vaccine program with preclinical data and $165 million in new funding
On Oct. 30, 2020, Icosavax announced the launch of the companyﾒs COVID-19 vaccine program with preclinical data on…
-
InBios awarded $12.67 million DOD contract to Increase domestic production of rapid point of care COVID-19 tests
On Oct. 30, 2020 InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
